UBS lowered the firm’s price target on Intuitive Surgical (ISRG) to $550 from $570 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Conmed downgraded to Neutral from Overweight at Piper Sandler
- Oracle, Nike upgraded: Wall Street’s top analyst calls
- Citi upgrades Intuitive Surgical to Buy on recent selloff
- Intuitive Surgical upgraded to Buy from Neutral at Citi
- IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors